These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 31551337)

  • 1. Population Genomics of GII.4 Noroviruses Reveal Complex Diversification and New Antigenic Sites Involved in the Emergence of Pandemic Strains.
    Tohma K; Lepore CJ; Gao Y; Ford-Siltz LA; Parra GI
    mBio; 2019 Sep; 10(5):. PubMed ID: 31551337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimal Antigenic Evolution after a Decade of Norovirus GII.4 Sydney_2012 Circulation in Humans.
    Parra GI; Tohma K; Ford-Siltz LA; Eguino P; Kendra JA; Pilewski KA; Gao Y
    J Virol; 2023 Feb; 97(2):e0171622. PubMed ID: 36688654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic cartography reveals complexities of genetic determinants that lead to antigenic differences among pandemic GII.4 noroviruses.
    Kendra JA; Tohma K; Ford-Siltz LA; Lepore CJ; Parra GI
    Proc Natl Acad Sci U S A; 2021 Mar; 118(11):. PubMed ID: 33836574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of GII.4 norovirus persistence in human populations.
    Lindesmith LC; Donaldson EF; Lobue AD; Cannon JL; Zheng DP; Vinje J; Baric RS
    PLoS Med; 2008 Feb; 5(2):e31. PubMed ID: 18271619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Norovirus Neutralized by a Monoclonal Antibody Targeting the Histo-Blood Group Antigen Pocket.
    Koromyslova AD; Morozov VA; Hefele L; Hansman GS
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic and biological characterization of a pandemic norovirus variant GII.4 Sydney 2012.
    Ge L; Chen X; Liu J; Zheng L; Chen C; Luo S; Guo P; Kong J; Song Y; Huo Y
    Virus Genes; 2020 Apr; 56(2):174-181. PubMed ID: 31912284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Within-host evolution results in antigenically distinct GII.4 noroviruses.
    Debbink K; Lindesmith LC; Ferris MT; Swanstrom J; Beltramello M; Corti D; Lanzavecchia A; Baric RS
    J Virol; 2014 Jul; 88(13):7244-55. PubMed ID: 24648459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolutionary dynamics of non-GII genotype 4 (GII.4) noroviruses reveal limited and independent diversification of variants.
    Tohma K; Lepore CJ; Ford-Siltz LA; Parra GI
    J Gen Virol; 2018 Aug; 99(8):1027-1035. PubMed ID: 29916802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunity.
    Debbink K; Lindesmith LC; Donaldson EF; Costantini V; Beltramello M; Corti D; Swanstrom J; Lanzavecchia A; Vinjé J; Baric RS
    J Infect Dis; 2013 Dec; 208(11):1877-87. PubMed ID: 23908476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic analyses of norovirus GII.4 variants in Finnish children from 1998 to 2013.
    Huhti L; Blazevic V; Puustinen L; Hemming M; Salminen M; Vesikari T
    Infect Genet Evol; 2014 Aug; 26():65-71. PubMed ID: 24837668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple antigenic sites are involved in blocking the interaction of GII.4 norovirus capsid with ABH histo-blood group antigens.
    Parra GI; Abente EJ; Sandoval-Jaime C; Sosnovtsev SV; Bok K; Green KY
    J Virol; 2012 Jul; 86(13):7414-26. PubMed ID: 22532688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of GII.4 noroviruses circulating among children with acute gastroenteritis in Pune, India: 2005-2013.
    Kulkarni R; Patel A; Bhalla S; Chhabra P; Cherian S; Chitambar SD
    Infect Genet Evol; 2016 Jan; 37():163-73. PubMed ID: 26611824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype distribution of norovirus around the emergence of Sydney_2012 and the antigenic drift of contemporary GII.4 epidemic strains.
    Zhang J; Shen Z; Zhu Z; Zhang W; Chen H; Qian F; Chen H; Wang G; Wang M; Hu Y; Yuan Z
    J Clin Virol; 2015 Nov; 72():95-101. PubMed ID: 26476326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phylogenetic Analyses Suggest that Factors Other Than the Capsid Protein Play a Role in the Epidemic Potential of GII.2 Norovirus.
    Tohma K; Lepore CJ; Ford-Siltz LA; Parra GI
    mSphere; 2017; 2(3):. PubMed ID: 28529975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Analysis of Reemerging GII.P16-GII.2 Noroviruses in 2016-2017 in China.
    Ao Y; Cong X; Jin M; Sun X; Wei X; Wang J; Zhang Q; Song J; Yu J; Cui J; Qi J; Tan M; Duan Z
    J Infect Dis; 2018 Jun; 218(1):133-143. PubMed ID: 29617875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Static and Evolving Norovirus Genotypes: Implications for Epidemiology and Immunity.
    Parra GI; Squires RB; Karangwa CK; Johnson JA; Lepore CJ; Sosnovtsev SV; Green KY
    PLoS Pathog; 2017 Jan; 13(1):e1006136. PubMed ID: 28103318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric GII.4 norovirus virus-like-particle-based vaccines induce broadly blocking immune responses.
    Debbink K; Lindesmith LC; Donaldson EF; Swanstrom J; Baric RS
    J Virol; 2014 Jul; 88(13):7256-66. PubMed ID: 24741081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-reactive neutralizing human monoclonal antibodies mapping to variable antigenic sites on the norovirus major capsid protein.
    Ford-Siltz LA; Tohma K; Alvarado GS; Kendra JA; Pilewski KA; Crowe JE; Parra GI
    Front Immunol; 2022; 13():1040836. PubMed ID: 36389818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic characterization of norovirus GII.4 variants circulating in Canada using a metagenomic technique.
    Petronella N; Ronholm J; Suresh M; Harlow J; Mykytczuk O; Corneau N; Bidawid S; Nasheri N
    BMC Infect Dis; 2018 Oct; 18(1):521. PubMed ID: 30333011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenetic mechanisms driving norovirus GII.4 antigenic variation.
    Lindesmith LC; Beltramello M; Donaldson EF; Corti D; Swanstrom J; Debbink K; Lanzavecchia A; Baric RS
    PLoS Pathog; 2012; 8(5):e1002705. PubMed ID: 22615565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.